WuXi Biologics Withdraws from BIO Convention Amid U.S. Tensions
Production specialist WuXi Biologics has opted out of the 2024 BIO International Convention following U.S. biosecurity [...]
Thermo Fisher’s $912.5 Million Acquisition Expands Clinical Research with CorEvitas Purchase
Thermo Fisher Scientific has acquired CorEvitas for $912.5 million from Audax Private Equityin to enhance its [...]
Effectiveness of Semaglutide in Real-World Weight Management
While recent studies confirm semaglutide's efficacy in significant weight reduction among overweight and obese adults, limited [...]
Insights into Treatment Resistant Depression in Portugal
The disease burden from treatment resistant depression (TRD) in Portugal has surpassed that of heart failure. [...]
Medline Acquires Ecolab’s Surgical Solutions Division in $950 Million Deal
Medline is set to acquire Ecolab's surgical solutions division for nearly $1 billion, increasing their presence [...]
AstraZeneca’s Advance into Respiratory Health at ATS 2024
AstraZeneca plans to highlight their comprehensive respiratory portfolio at the American Thoracic Society (ATS) International Conference [...]
Enhanced Efficacy of a Cell-Based Influenza Vaccine
The superior effectiveness of the cell-based quadrivalent influenza vaccine (QIVc) compared to the traditional egg-based vaccine [...]
Strategic Shifts for BioMarin’s Gene Therapy Roctavian Amid Market Challenges
BioMarin's gene therapy for hemophilia A, Roctavian, received approval in Europe in 2022 and the U.S. [...]
RWE Solutions Market Predicted to Reach $78.83 Billion by 2030
The global Real World Evidence (RWE) Solutions Market is projected to grow substantially, from USD 43.22 [...]
3 Billion Data Points Inform Verantos’ IBD Registry for Advanced Patient Care Research
Verantos, a leader in real-world evidence, has launched their Inflammatory Bowel Disease (IBD) Pragmatic Registry, which [...]
Eleos Technology Cuts Documentation Time and Enhances Care Quality
Eleos, founded by Dror Zaide, uses innovative technology to streamline documentation for behavioral health providers, shortening [...]
Partnership Between Parexel and Palantir to Enhance Clinical Trials
Parexel, a leading clinical research organization, has partnered with Palantir Technologies with the intent of using [...]
$9.75M Commons Clinic Investment Revolutionizes Orthopedic Treatment
Commons Clinic is helping reshape orthopedic healthcare by investing $9.75M in Marina Orthopedic & Spine Institute [...]
Reducing Medication Errors in Cancer Treatment with Insights from the AMBORA Trial
A recent publication from Cuba et al. highlights the AMBORA trial, which demonstrated how common medication [...]
Ibrutinib’s Success in CLL Treatment: Supported by Real World Data
Final results are in from the EVIdeNCE study, which analyzed 309 chronic lymphocytic leukemia (CLL) patients [...]
EU Probes China’s Medical Device Market Access
The European Commission has initiated an investigation into China's public procurement practices for medical devices, increasing [...]
Implications for Medical Affairs Teams in 2024 and Beyond
In 2024, medical affairs teams are pivotal in driving strategic impact within the pharmaceutical industry. They [...]
Aerial Contagion: Redefining Airborne Pathogens
The World Health Organization (WHO) has recently announced a revision of its classification of airborne pathogens, [...]
Bridging Urban-Rural Healthcare Gaps Through Real-World Data
Medical research and clinical trials have historically favored urban communities, resulting in an underrepresentation of rural [...]
Chiesi Focuses on Patient-Centered Care in Fabry Disease
Chiesi Global Rare Diseases has published survey results in the Orphanet Journal of Rare Diseases that [...]
ISPOR 2024: Keynote Speakers and Sessions Announced
The ISPOR 2024 conference, a key event for Health Economics and Outcomes Research (HEOR), will take [...]
Forecast of the Global Real World Evidence (RWE) Solutions Market
The Global Real World Evidence (RWE) Solutions Market is forecasted to grow from 2.7 billion (USD) [...]
Bristol Myers Squibb Expands Partnership with Cellares in $380 Million Deal
Bristol Myers Squibb (BMS) has reinforced its collaboration with Cellares by signing a $380 million agreement, [...]
Entyvio: New Subcutaneous Option for Crohn’s Disease Patients
Takeda's Entyvio, a medication for Crohn's disease, has been approved for a subcutaneous (SC) formulation. Originally [...]
Urgent Transparency Needed in H5N1 Bird Flu Outbreaks Affecting U.S. Dairy Cattle
As H5N1 bird flu spreads across U.S. dairy cattle herds, significant concerns have arisen regarding the [...]